Publications by authors named "Marion Marcaillou"
Melanoma Res
December 2020
Article Synopsis
- Brain metastases are a serious and common issue in metastatic melanoma, which can lead to death, but immunotherapy and targeted therapy have improved survival rates.
- A study analyzed 293 patients with metastatic melanoma to see if immunotherapy could lower the occurrence of brain metastases, finding that those treated with immune checkpoint inhibitors (ICI) had a significantly lower incidence compared to others.
- Specifically, patients receiving anti-PD-1 therapy saw nearly a 70% reduction in brain metastasis risk, indicating that immunotherapy may provide protective benefits against the development of brain metastases in advanced melanoma.
